Cochrane · systematic review · CD004504
Herbal medicine for low‐back pain
Oltean, H, Robbins, C, van Tulder, MW, et al. · Cochrane Database of Systematic Reviews · 2014 · Cochrane Library
Back and NeckAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
10
current version
GRADE rated
10
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 6 · 60%Low 2 · 20%Moderate 2 · 20%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Summary of findings table 1: Brazilian arnica extract compared to placebo for patients with non‐specific chronic back pain or soft tissue pain
Population: patients with back pain
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Pain reduction based on Pain VAS instrument 0‐100 scale Summary of findings table 1: Brazilian arnica extract vs placebo | no estimate extracted | 20 participants | Very low Downgraded: risk of bias |
Summary of findings table 2: Topical capsaicin cream or plaster compared to placebo for patients with non‐specific chronic back pain or soft tissue pain
Population: patients with chronic LBP or soft tissue pain
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Pain perception according to the Pain VAS scale 0‐10 Summary of findings table 2: Topical capsaicin cream or plaster vs placebo | no estimate extracted | 755 participants | Moderate Downgraded: risk of bias |
Summary of findings table 3: Topical capsaicin cream compared with placebo for patients with acute non‐specific LBP
Population: patients with acute mechanical LBP
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Pain evaluation on a 10 cm linear scale Summary of findings table 3: Topical capsaicin cream vs placebo | no estimate extracted | 40 participants | Very low Downgraded: risk of bias |
Summary of findings table 4: H. procumbens compared to placebo for non‐specific chronic back pain
Population: patients with chronic back pain
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Arhus pain index scale 0‐130 Summary of findings table 4: H. procumbens vs placebo | no estimate extracted | 315 participants | Low Downgraded: risk of bias |
Summary of findings table 5: H. procumbens extract compared to Vioxx® for non‐specific chronic LBP
Population: patients with chronic LBP
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Modified Arhus Index Scale 0‐120 Summary of findings table 5: H. procumbens extract vs Vioxx® | no estimate extracted | 88 participants | Very low Downgraded: risk of bias |
Summary of findings table 6: Willow bark extract compared to placebo for non‐specific chronic LBP
Population: patients with chronic LBP
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Pain VAS Scale 0‐10 Summary of findings table 6: Willow bark extract vs placebo | no estimate extracted | 261 participants | Moderate Downgraded: risk of bias |
Summary of findings table 7: Willow bark extract compared to rofecoxib for non‐specific chronic LBP
Population: patients with chronic LBP
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Arhus Index Scale 0‐130 Pain VAS Scale 0‐10 Summary of findings table 7: Willow bark extract vs rofecoxib | no estimate extracted | 228 participants | Very low Downgraded: risk of bias |
Summary of findings table 8: Comfrey root extract compared to placebo for acute lower and upper back non‐specific pain
Population: patients with acute lower and upper back pain
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Pain VAS sum (decrease) on active standardized movement (mm) Summary of findings table 8: Comfrey root extract vs placebo | no estimate extracted | 120 participants | Low Downgraded: risk of bias |
Summary of findings table 9: Lavender oil acupressure massage and acupoint stimulation compared to usual treatment for acute non‐specific LBP
Population: patients with acute LBP
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Pain VAS 0‐10 scale Summary of findings table 9: Lavender oil acupressure massage and acupoint stimulation vs usual treatment | no estimate extracted | 61 participants | Very low Downgraded: risk of bias |
Summary of findings table 10: Spiroflor SRL compared to CCC for chronic non‐specific LBP
Population: patients with acute and chronic LBP
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Pain VAS 0‐100 scale Summary of findings table 10: Spiroflor SRL vs CCC | no estimate extracted | 161 participants | Very low Downgraded: risk of bias |